Pharmaceutical composition for controlling body mass gain comprising s-phenotropil

Abstract

The invention relates to medicine, in particular S-Phenotropil ((S)-2-(2-oxo-4-phenylpyrrolidin-1-yl)acetamide) containing pharmaceutical compositions and their use in control of body mass gain.

1 ) A pharmaceutical composition for controlling body mass gain in humans and animals comprising S-phenotropil ((S)-2-(2-oxo-4-phenylpyrrolidin-1-yl)acetamide) in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier. 
     
     
         2 ) The pharmaceutical composition according to  claim 1 , for oral or sublingual administration in a form of tablet, coated tablet, capsule, caplet, dragee or granule, powder or solution that contains 0.01-0.5 g of the active substance by weight in each tablet, capsule, dragee or a dose of granules or powder or it is a 0.01-20% solution or syrup for oral administration. 
     
     
         3 ) The pharmaceutical composition according to  claim 1 , for parenteral administration in a form of sterile solution that contains 0.01-0.5 g of the active substance in each dose for parenteral administration together with a pharmaceutically acceptable carrier. 
     
     
         4 ) The pharmaceutical composition according to  claim 1 , which is distinguished by 10-500 mg content of S-phenotropil in it. 
     
     
         5 ) The pharmaceutical composition according to  claims 1  and  3  for parenteral administration distinguished in that solution contains 0.01-10 mg/ml S-phenotropil. 
     
     
         6 ) The pharmaceutical composition according to  claim 1  for prevention and treatment of diseases which have a pathogenesis related to obesity. 
     
     
         7 ) The pharmaceutical composition according to  claim 1  for prevention and treatment of diseases where disease is selected as such which is caused by sedentary lifestyle and increased appetite. 
     
     
         8 ) The pharmaceutical composition according to  claim 1  for prevention and treatment of diseases where diseases belongs to the group of diseases that include metabolic syndrome and diabetes mellitus. 
     
     
         9 ) A pharmaceutical composition comprising S-phenotropil for prevention and treatment of diseases related to the increase in body mass gain in humans and animals after using medications.